How to Inject Mounjaro: Step-by-Step Instructions

Mounjaro (tirzepatide) comes in a single-dose, prefilled autoinjector pen that you use once a week as a subcutaneous injection, meaning the medication goes into the fat layer just beneath your skin. The process is straightforward once you understand the device, but small missteps with the pen are surprisingly common, and getting the technique right from the start saves you unnecessary frustration and wasted doses.

What Comes in the Box

Each Mounjaro pen is a disposable, single-use autoinjector. You do not need to attach a separate needle, draw up medication from a vial, or dial a dose. The pen handles all of that internally. When you press the button on the pen, a hidden needle extends, delivers the medication, and retracts automatically. You never see the needle during normal use, which is a real advantage if needles make you uneasy.

Each box contains four pens for a month’s supply (one injection per week). Pens are color-coded by dose strength, so the color of your pen cap changes if your prescriber increases your dose. Before you use a pen, check the medicine window on the side. The liquid should be clear and colorless to slightly yellow. If it looks cloudy, discolored, or has particles floating in it, do not use that pen.

Storing Your Pens and Getting One Ready

Unused Mounjaro pens belong in the refrigerator, between 2°C and 8°C (36°F to 46°F). Do not freeze them. If a pen accidentally freezes, throw it away and use a new one. You can keep a pen at room temperature (up to 30°C or 86°F) for up to 21 days if needed, which is useful for travel. Once those 21 days pass, the pen must be discarded even if there is medication inside.

Cold medication stings more going in. Most people find it more comfortable to pull the pen out of the fridge about 30 minutes before injecting, letting it reach room temperature naturally. Do not try to speed this up by heating the pen in warm water or a microwave.

Choosing Your Injection Site

Mounjaro can be injected into three areas of your body: the abdomen (at least two inches away from the belly button), the front of either thigh, or the back of either upper arm. Subcutaneous administration of tirzepatide in any of these three locations results in similar drug exposure, so you are not getting a stronger or weaker dose depending on which spot you pick.¹ Choose whichever site feels most comfortable and accessible.

A few practical notes on each site:

Abdomen: This is the most popular choice because the skin is easy to reach and tends to have enough subcutaneous fat for a comfortable injection. Stay at least two inches from the navel and avoid any area with a scar, bruise, or stretch mark.
Thigh: Use the front and outer part of the thigh, roughly in the middle third between your knee and hip. Avoid the inner thigh.
Upper arm: This site works best if someone else is giving you the injection, since it is hard to reach on your own and difficult to pinch the skin properly behind your own arm.

Step-by-Step Injection

Once the pen has warmed to room temperature and you have washed your hands, you are ready. Here is the full process:

Pull off the gray base cap: Grip the pen and pull the gray cap straight off the bottom. You will see a short, flat needle guard underneath. Do not touch it, and do not try to remove it. The pen is now unlocked. Use it within five minutes of removing the cap to avoid the medication drying on the needle tip.
Position the pen: Place the flat gray base of the pen flush against your chosen injection site. The pen needs to sit flat and firm against your skin. You do not need to pinch the skin unless you are very lean, in which case a gentle pinch of the skin fold can help ensure the needle reaches the subcutaneous layer.
Press and hold the injection button: With the base pressed against your skin, press the purple injection button on top of the pen. You will hear a loud click, which means the needle has been inserted and the injection has begun. Keep holding the pen firmly against your skin. Do not lift it yet.
Wait for the second click: After several seconds, you will hear a second click and the gray plunger visible in the medicine window will have moved to the bottom. This means the full dose has been delivered. Some people feel a slight sting or pressure during this time; that is normal.
Hold for a few more seconds: After the second click, keep the pen against your skin for at least five to ten seconds. This gives the medication time to disperse into the tissue and reduces the chance of any liquid leaking back out through the puncture site.
Remove the pen: Lift the pen straight up and away from your skin. The needle guard will lock into place automatically, covering the needle. You cannot reuse the pen.

That is the entire injection. The active part usually takes under 15 seconds from the first click to the second. If the medicine window still shows medication after the second click, or if you are not sure the injection completed, do not try to re-inject. Contact your pharmacist or prescriber to figure out what happened.

What to Do Right After

You may see a tiny drop of blood or a small bead of liquid at the injection site. A small surface drop of medication on the skin or needle tip can happen for ordinary mechanical reasons: the skin does not always seal instantly after the needle retracts, and a trace amount of medication can remain on the needle itself. This does not mean you lost a meaningful portion of your dose. Press a clean cotton ball or gauze pad gently against the site for a few seconds. Do not rub the area.

Dispose of the used pen in a sharps container, not your regular trash. If you do not have a sharps container yet, a sturdy plastic container with a screw-on lid (like a laundry detergent jug) works as a temporary solution. Check your local regulations for how to dispose of full sharps containers, since rules vary by municipality.

Why Rotating Injection Sites Matters

Injecting in the same spot repeatedly can cause a condition called lipohypertrophy, where the fat tissue under the skin hardens into a rubbery lump. These lumps are not dangerous on their own, but medication injected into hardened tissue does not absorb properly, which can make your dose less effective. One documented case of poor medication absorption was directly attributed to lipohypertrophy caused by repeated injections in the same area.²

Rotate your injection site each week. If you inject in the abdomen this week, try the left thigh next week and the right thigh the week after. Even within the same general area, move the exact spot by at least an inch or two each time. Rotating sites and using correct injection technique are considered essential for minimizing complications and the recurrence of injection site reactions.³

Common Pen Errors and How to Avoid Them

Mistakes with injectable medication pens are more common than most people realize. A poison center analysis of GLP-1 receptor agonist exposures found that therapeutic errors accounted for about 91% of cases, and roughly one in five of those errors happened during initial use of the pen.⁴ In other words, the first time you use the device is when you are most likely to make a mistake. Here are the errors that trip people up most often:

Not removing the base cap fully: Across injectable pen devices more broadly, failing to properly remove a needle cap is one of the most documented user errors. In some reported cases, patients attempted to inject through an inner cap they did not realize was present, meaning they received no medication at all.² With Mounjaro, there is only one cap (the gray base cap), but the lesson is the same: make sure it is completely removed before you begin.
Lifting the pen too soon: If you pull the pen away before the second click, you may not get the full dose. Wait until you hear the second click and the plunger has moved fully down in the window.
Not pressing the pen firmly enough: The pen needs to be flat against your skin with a bit of pressure for the needle to deploy properly. Holding it at an angle or hovering it above the skin can result in an incomplete injection.
Injecting through clothing: Always inject into bare, clean skin. Injecting through fabric increases infection risk and can block the needle.
Confusing dose strengths after a change: If your prescriber increases your dose, you will receive pens with a different cap color. Errors have been documented when patients switch between formulations or doses without adequate education about the new device.² Always read the label on the new box and confirm the dose with your pharmacist.

The good news is that even when errors occur with GLP-1 receptor agonists, the outcomes are usually mild. In the poison center study mentioned above, about two-thirds of patients who experienced an error reported no symptoms at all, and the majority were safely managed at home. Hypoglycemia (dangerously low blood sugar) was rare and mostly occurred when a GLP-1 medication was combined with insulin.⁴

Dealing with Injection Site Reactions

Some redness, mild swelling, or itching at the injection site is common and not a sign that anything has gone wrong. These reactions typically show up within hours of the injection and are localized to the spot where the needle went in. They tend to resolve on their own within one to three days.³ An ice pack or a cool compress applied to the area can reduce discomfort.

A reaction that spreads well beyond the injection site, involves hives, or comes with difficulty breathing, dizziness, or a rapid heartbeat is not a normal injection site reaction. That pattern points to a possible allergic response and warrants immediate medical attention. These serious reactions are uncommon, but knowing the difference between a localized red patch and a systemic reaction matters.

Picking Your Day and Time

Mounjaro is injected once every seven days. You can choose any day of the week that works for your schedule, and you can inject at any time of day, with or without food. Consistency helps you remember, so picking the same day and a similar time each week is a good habit. If you need to change your injection day, you can do so as long as at least three days (72 hours) have passed since your last dose.

If you miss a dose, take it as soon as you remember, as long as your next scheduled dose is at least four days away. If it is closer than that, skip the missed dose entirely and resume your regular schedule. Do not double up to make up for a missed injection.

The Dose Escalation Schedule

Mounjaro is not a one-size-fits-all medication. Everyone starts at the lowest dose (2.5 mg) for the first four weeks. This starting dose is primarily about letting your body adjust to the medication and minimizing gastrointestinal side effects like nausea, rather than achieving the full therapeutic effect. After four weeks, the dose increases to 5 mg.

From there, your prescriber may increase the dose further in 2.5 mg increments (to 7.5 mg, 10 mg, 12.5 mg, or the maximum of 15 mg) based on how you respond and what you can tolerate. Each dose level is maintained for at least four weeks before considering an increase. The injection technique stays identical at every dose level; only the pen and its cap color change. You do not need to adjust how long you hold the pen or alter your technique in any way when your dose goes up.

Managing Nausea and Other GI Side Effects

The most common side effects of tirzepatide are gastrointestinal: nausea, diarrhea, decreased appetite, and occasionally vomiting or constipation. These side effects are related to how the drug works in your body, not to your injection technique. They tend to be worst during the first few weeks on a new dose and often improve as your body adjusts.

A few practical strategies help:

Eat smaller meals: Large portions are more likely to trigger nausea. Eating smaller, more frequent meals throughout the day gives your slowed digestive system less to handle at once.
Avoid high-fat and greasy foods: These sit in the stomach longer and tend to worsen nausea in people taking GLP-1 based medications.
Stay hydrated: Nausea and diarrhea both increase your fluid needs. Sipping water, broth, or electrolyte drinks throughout the day helps.
Time your injection strategically: Some people find that injecting in the evening or right before bed helps them sleep through the initial wave of nausea that can follow a dose.

If nausea or vomiting is severe enough that you cannot keep food or liquids down, contact your prescriber. The dose escalation schedule exists specifically so your body can acclimate gradually, and staying at a lower dose for an extra cycle is far better than pushing through unbearable side effects.

Traveling with Mounjaro

Bringing Mounjaro on a trip requires a little planning but is not complicated. Unused pens can stay out of the fridge for up to 21 days at room temperature, which covers most vacations. For longer trips or hot climates, a small insulated medication travel case with a cool pack keeps the pens in the right temperature range. Avoid putting pens in checked luggage during air travel, since cargo holds can reach freezing temperatures. Keep them in your carry-on bag.

If you are flying, bring your pens in their original packaging with the pharmacy label visible, along with a copy of your prescription. Security screeners at airports are accustomed to seeing autoinjector pens and injectable medications in carry-on bags. You do not typically need a doctor’s letter, though having one can speed things up if questions arise at international borders. Pack a small sharps container or a hard-sided travel container for disposal after your injection, since hotels and rental properties will not have one on hand.

1
Health Sciences Review. Bumps and humps in the success of Tirzepatide as the first GLP1 and GIP receptor agonist
2
PubMed. Patient errors in use of injectable antidiabetic medications: A need for improved clinic-based education
3
Anais Brasileiros de Dermatologia. Tirzepatide in dermatology: cutaneous adverse events, emerging therapeutic roles, and cosmetic implications – A comprehensive review
4
PubMed Central. GLP-1 Receptor Agonist Exposures Are Increasingly Common and Generally Associated with Mild Symptoms: A Single Poison Center Experience